Suppression of lymphocyte proliferation by a nonspecific factor produced by the Burkitt lymphoma-derived lymphoblast cell line
- PMID: 149758
- DOI: 10.1007/BF02616109
Suppression of lymphocyte proliferation by a nonspecific factor produced by the Burkitt lymphoma-derived lymphoblast cell line
Abstract
The DAUDI lymphoblast cell line derived from a patient with Burkitt lymphoma was obtained from two different sources. One of these (DAUDI-I) produced a factor that inhibited lymphocyte proliferation in both human and mouse regardless of the stimulator, i.e. allogeneic lymphocytes or mitogens. Glutaraldehyde treatment eliminated production of the factor and demonstrated that DAUDI-I was capable of stimulating normal lymphocytes in MLR. A second DAUDI cell line (DAUDI-S) did not produce the inhibitory factor and was capable of MLR stimulation.
Similar articles
-
Suppressor substance produced by the K562 cell line in vitro.J Surg Oncol. 1983 May;23(1):16-20. doi: 10.1002/jso.2930230106. J Surg Oncol. 1983. PMID: 6221160
-
Serological distinction between DR antigens and lymphocyte activating determinants.Tissue Antigens. 1981 Feb;17(2):149-61. doi: 10.1111/j.1399-0039.1981.tb00679.x. Tissue Antigens. 1981. PMID: 6165093
-
Effect of anti-beta2-microglobulin on antigen and allogeneic lymphocyte-induced proliferation of human lymphocytes.J Immunol. 1975 Jun;114(6):1766-70. J Immunol. 1975. PMID: 47878
-
Paired Epstein-Barr virus (EBV)-negative and EBV-converted Burkitt lymphoma lines: stimulatory capacity in allogeneic mixed lymphocyte cultures.Int J Cancer. 1987 Nov 15;40(5):691-7. doi: 10.1002/ijc.2910400521. Int J Cancer. 1987. PMID: 2824386
-
Cellular immunity to human tumor-associated antigens. A review.Isr J Med Sci. 1973 Mar;9(3):300-7. Isr J Med Sci. 1973. PMID: 4575654 Review. No abstract available.